The Report Guru

 According to the new market research report " Minimally Invasive Surgical Instruments Market by Product (Handheld Instruments, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestinal), End User (Hospitals, Ambulatory Surgery Centers and Clinic) - Global Forecast to 2025", published by MarketsandMarkets™, the Minimally Invasive Surgical Instruments Market is projected to reach USD 32.7 billion by 2025 from USD 20.1 billion in 2019, at a CAGR of 8.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Market growth is largely driven by factors such as the advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe. However, the uncertain regulatory framework in the medical device industry is a major factor restraining the growth of this market during the forecast period. Handheld instruments accounted f...

According to the new market research report ' Laboratory Informatics Market by Type of Solution (LIMS, ELN, ECM, SDMS), Component (Software, Service), Deployment, Industry (Pharmaceutical, Biotechnology, Chemical, Agriculture, Petrochemical, oil & gas) - Global Forecasts to 2024', published by MarketsandMarkets™, the global Laboratory Informatics Market is estimated to reach USD 3.8 billion by 2024 from USD 2.6 billion in 2019, at a CAGR of 7.5% during the forecast period. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203037633 The increasing need for laboratory automation; the development of integrated lab informatics solutions; the need to comply with regulatory requirements; and the growing demand in biobanks/biorepositories, academic research institutes, and CROs are the major factors driving the growth of the Laboratory Informatics Market. On the other hand, lack of integration standards and high maintenance and services ...

  According to research report the Lab Informatics Market is estimated to reach USD 3.8 billion by 2024 from USD 2.6 billion in 2019, at a CAGR of 7.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203037633 The increasing need for laboratory automation; the development of integrated lab informatics solutions; the need to comply with regulatory requirements; and the growing demand in biobanks/biorepositories, academic research institutes, and CROs are the major factors driving the growth of the laboratory informatics market. On the other hand, lack of integration standards and high maintenance and services cost are expected to restrain the growth of this market in the coming years. The services segment accounted for the largest share of the market in 2018. Based on components, the Lab Informatics Market is segmented into services and software. The services segment dominated this market in 2018. The large share ...

  The global in-vitro toxicology testing market size is projected to reach USD 12.7 billion by 2024 from USD 8.1 billion in 2019, growing at a CAGR of 9.3%. The opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth factors for this market. Also, the increasing focus of the pharmaceutical and cosmetics industries on using in-vitro methods for product testing along with the improvement in silico methods for predictive toxicology studies are expected to offer significant opportunities for market growth in the coming years. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065 Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex...

According to the new market research report Interventional Cardiology Market size is projected to reach USD 21.2 billion by 2025 from USD 13.8 billion in 2020, at a CAGR of 8.9%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548 The Growth in the Interventional Cardiology Devices Market is driven mainly by the rapid growth in the geriatric population and the associated increase in the prevalence of coronary artery diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries. The old/normal balloons segment accounted for the largest share of the angioplasty balloons market in 2019. Based on type, the angioplasty balloons market is segmented into old/normal balloons, cutting and scoring balloons, and drug-eluting balloons. In 2019, the old/normal balloons segment accounted for the largest share of the angioplasty balloons market. The large share of this segment can be attributed to a increasing it...

According to the new market research report spinal surgery devices market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%. Advancements in spine surgery technologies, increasing incidence of spinal disorders, the launch of advanced bone grafting products, and the increasing adoption of minimally invasive spine surgeries are driving the growth of the spinal implants and surgery devices market. However, the high cost of spinal surgery and uncertainties surrounding reimbursement are expected to restrain the growth of this market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712 Based on product, the spinal surgery devices market is segmented into thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, non-fusion devices, vertebral compression fracture treatment devices, spinal decompression devices, and spine bone stimulators. The thoracic ...

According to the market research report Liquid Biopsy Market is expected to reach $2,047.9 Million by 2022 from an estimated $715.7 Million in 2017, at a CAGR of 23.4%. Some of the key factors driving the growth of this market include increasing preference for noninvasive procedures, increasing prevalence of cancer and availability of funding for liquid biopsy R&D. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350 The key players in the global liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US). By clinical application, the therapy selection segment is expected to account fors the largest market share in 201...